Yader Sandoval Pichardo, MD
Cardiovascular Disease · Minneapolis, MNNPI 1477864304
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Heartflow, Inc. at 32.1% of the total. 2025 is the largest year on record at $77,361, more than ten times the $338 reported in 2019. Among cardiovascular disease clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 163 payments — averaging $965.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heartflow, Inc.$51K
- Roche Diagnostics International Ltd$35K
- Abbott$31K
- Philips North America LLC$15K
- GE HealthCare$7K
- Medtronic$4K
- plus $14K from 10 others
Across 142 payments — averaging $3828.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cathworks, Inc.$252K
- Roche Diagnostics Operations, Inc.$186K
- Abbott$100K
- Cleerly, Inc.$5K
What the payments were for
- Consulting fees$84,67354%
- Speaking & faculty fees$17,41011%
- Travel & lodging$26,32217%
- Food & beverage$8,9716%
- Education$20,00013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heartflow, Inc. | 27 | $50,516 |
| Roche Diagnostics International Ltd | 10 | $35,129 |
| Abbott | 53 | $30,967 |
| Philips North America LLC | 21 | $14,964 |
| GE HealthCare | 8 | $6,841 |
| Medtronic | 9 | $4,469 |
| Cleerly, Inc. | 4 | $3,729 |
| Cathworks, Inc. | 6 | $3,664 |
| Boston Scientific | 5 | $3,496 |
| ZOLL Circulation Inc | 2 | $1,235 |
| Siemens Medical Solutions USA, Inc. | 6 | $948 |
| Shockwave Medical, Inc | 4 | $504 |
| Abiomed | 3 | $496 |
| Asahi Intecc USA, Inc. | 2 | $217 |
| Reflow Medical Inc | 2 | $101 |
| Kestra Medical Technology Services, Inc. | 1 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$50,138
- (9520) IGT Devices Undivided$14,339
- DRAGONFLY OPSTAR$8,769
- FFRangio$7,522
- XIENCE SIERRA$6,475
- Architect$6,210
- OPTIS$5,746
- cobas 6800 System$3,955
- AVVIGO Guidance System$3,125
- Ultreon$1,954
- ALLIA$1,443
- TherOx DS2 Console$1,200
- Catheter$1,200
- Downstream Cartridge$1,200
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$376
- Impella$360
- ONYX FRONTIER$279
- Xience V coronary stent system$222
- MitraClip$180
- ASAHI PTCA Guide Wire$173
How this compares
$157,376 in reported general payments places this provider in the 95th percentile of 451 cardiovascular disease providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 83 | $100,656 |
| Metoprolol Succinate | 162 | $2,380 |
| Ranolazine ErRanolazine | 25 | $2,323 |
| Rosuvastatin Calcium | 89 | $1,443 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 65 | $1,364 |
| ClopidogrelClopidogrel Bisulfate | 69 | $898 |
| Amlodipine Besylate | 61 | $592 |
| Ezetimibe | 24 | $462 |
| Losartan Potassium | 23 | $462 |
| Nitroglycerin | 24 | $364 |
| Metoprolol Tartrate | 27 | $351 |
| Atorvastatin Calcium | 30 | $325 |
| Spironolactone | 18 | $255 |
| Lisinopril | 20 | $223 |
| Carvedilol | 37 | $186 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Minneapolis
- Jeffrey ChambersMinneapolis$3.2M
- Markus MeyerMinneapolis$786K
- Robert SchwartzMinneapolis$502K
- Robert VantasselMinneapolis$493K
- Nedaa SkeikMinneapolis$453K
- Joao CavalcanteMinneapolis$384K
- Inderjit AnandMinneapolis$384K
- David HurrellMinneapolis$205K
- Charles HerzogMinneapolis$157K
- Tamas AlexyMinneapolis$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.